4.5 Article

Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease

期刊

ARCHIVES OF DISEASE IN CHILDHOOD
卷 98, 期 2, 页码 97-102

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/archdischild-2011-301256

关键词

-

向作者/读者索取更多资源

Objective To describe the significance of pericardial effusion (PE), mitral regurgitation (MR) and impaired systolic function in predicting coronary artery lesions (CAL) at diagnosis and follow-up in Kawasaki disease (KD). Design Echocardiographic records on admission, at 1-3 weeks of illness, and at 6-8 weeks of illness were retrospectively retrieved in children with acute KD treated by intravenous immunoglobulins. Setting, patients The study included 194 consecutive children (113 male; median age 2.1 years) in a paediatric cardiology tertiary care centre, from 1988 to 2007. Results Overall, children with CAL (64/194) were more likely to have PE (OR=3.00, CI 1.34 to 6.72) and MR (OR=2.51, CI 1.22 to 5.16) at diagnosis; PE was the sole echocardiographic abnormality associated with CAL in multivariable analysis. These abnormalities were predictive of the presence of CAL at the first echocardiography in the acute phase of the disease only. MR, systolic dysfunction and PE were not associated with persistence of CAL in the convalescent phase. Male gender, CAL size and resistance to immunoglobulin treatment were independent factors predictive of the persistence of CAL. Conclusions Children with MR or PE should undergo careful assessment of coronary status at diagnosis. However, PE or MR at diagnosis is not predictive of persistent CAL at follow-up.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemistry & Molecular Biology

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases

Alessandra Bettiol, Giuseppe Lopalco, Giacomo Emmi, Luca Cantarini, Maria Letizia Urban, Antonio Vitale, Nunzio Denora, Antonio Lopalco, Annalisa Cutrignelli, Angela Lopedota, Vincenzo Venerito, Marco Fornaro, Alfredo Vannacci, Donato Rigante, Rolando Cimaz, Florenzo Iannone

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Rheumatology

Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases

Nienke M. Ter Haar, Charlotte Eijkelboom, Luca Cantarini, Riccardo Papa, Paul A. Brogan, Isabelle Kone-Paut, Consuelo Modesto, Michael Hofer, Nicolae Iagaru, Sarka Fingerhutova, Antonella Insalaco, Francesco Licciardi, Yosef Uziel, Marija Jelusic, Irina Nikishina, Susan Nielsen, Efimia Papadopoulou-Alataki, Alma Nunzia Olivieri, Rolando Cimaz, Gordana Susic, Valda Stanevica, Marielle van Gijn, Antonio Vitale, Nicolino Ruperto, Joost Frenkel, Marco Gattorno

ANNALS OF THE RHEUMATIC DISEASES (2019)

Editorial Material Rheumatology

What is the real role of ultrasound in the management of juvenile idiopathic arthritis?

Rolando Cimaz, Teresa Giani, Roberto Caporali

ANNALS OF THE RHEUMATIC DISEASES (2020)

Review Rheumatology

Association of juvenile idiopathic arthritis and morphea: a case series

Teresa Giani, Anna Madera, Rolando Cimaz

CLINICAL RHEUMATOLOGY (2020)

Article Rheumatology

Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis

Nicolino Ruperto, Hermine Brunner, Nikolay Tzaribachev, Gabriel Vega-Cornejo, Ingrid Louw, Rolando Cimaz, Jason Dare, Graciela Espada, Enrique Faugier, Manuel Ferrandiz, Valeria Gerloni, Pierre Quartier, Clovis Artur Silva, Linda Wagner-Weiner, Yash Gandhi, Julie Passarell, Marleen Nys, Robert Wong, Alberto Martini, Daniel J. Lovell

Summary: In patients aged 2-17 years with pJIA, no evidence of association between higher levels of exposure to IV ABA or SC ABA and incidence of infection was observed.

JOURNAL OF RHEUMATOLOGY (2021)

Editorial Material Rheumatology

Ballet foot in a boy

Teresa Giani, Maurizio Gattinara, Rolando Cimaz

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)

Review Pediatrics

Drug Treatment of Low Bone Mass and Other Bone Conditions in Pediatric Patients

Stefania Costi, Teresa Giani, Francesco Orsini, Rolando Cimaz

Summary: Osteoporosis can affect young individuals, although it is rare. Bone mass increases during childhood and peaks between the second and third decades, then gradually declines. Various factors, such as genetic disorders, chronic illnesses, and certain medications, can impact bone health. Diagnosis in young patients is based on the criteria defined by the International Society for Clinical Densitometry (ISCD) in 2013. Identification and monitoring of high-risk factors are important. Simple interventions, such as addressing underlying causes, minimizing negative effects of medications on bone, or increasing calcium and vitamin D intake, can protect bone mass. Pharmacological treatment may be necessary in selected cases. Bisphosphonates are the main therapeutic agent for children with significant skeletal fragility and can also be used for other bone conditions. Denosumab, an anti-RANKL antibody, could be an alternative treatment option. Long-term effects and safety of denosumab in children are currently being evaluated in clinical trials.

PEDIATRIC DRUGS (2022)

Review Acoustics

Ultrasound versus physical examination in predicting disease flare in children with juvenile idiopathic arthritis: a systematic literature review and qualitative synthesis

Orazio De Lucia, Teresa Giani, Roberto Caporali, Rolando Cimaz

Summary: This systematic review analyzed the predictive value of ultrasound (US) in assessing subclinical synovitis in juvenile idiopathic arthritis (JIA). The study found that US may have the potential to predict flare in JIA, but more research is needed to draw definitive conclusions.

MEDICAL ULTRASONOGRAPHY (2022)

Article Rheumatology

Canakinumab treatment in a young girl with refractory chronic recurrent multifocal osteomyelitis associated with pyoderma gangrenosum

Sabrina Acierno, Francesca Angrisani, Achille Marino, Roberto Felice Caporali, Rolando Cimaz, Teresa Giani

Summary: CRMO is a bone inflammatory disorder characterized by osteolytic lesions, with no standardized therapies available. Treatment with an anti-IL-1 beta antibody may show promise in managing the condition.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2022)

Meeting Abstract Rheumatology

USE OF ETANERCEPT BIOSIMILAR IN JIA: PRELIMINARY EXPERIENCE USING REAL WORLD DATA

Marco Marinelli, Achille Marino, Gabriele Simonini, Rolando Cimaz, Teresa Giani

ANNALS OF THE RHEUMATIC DISEASES (2019)

Meeting Abstract Rheumatology

CENTRAL NERVOUS SYSTEM VASCULITIS PRECEDING

Edoardo Marrani, Gabriele Simonini, Eleonora Fusco, Ilaria Maccora, Anna Rosati, Rolando Cimaz, Teresa Giani

ANNALS OF THE RHEUMATIC DISEASES (2019)

Meeting Abstract Rheumatology

THE CONSEQUENCES OF THE PROVISIONAL PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIALS ORGANISATION JUVENILE IDIOPATHIC ARTHRITIS CLASSIFICATION CRITERIA

Vera Mars, Joost F. Swart, Gabriella Giancane, Sytze De Roock, Anne Estmann, Marija Jelusic, Estefania Moreno Ruzafa, Jaime de Inocencio, Jelena Vojinovic, Agustin Remesal, M. Laday, Rolando Cimaz, A. V. Cochino, Inmaculada Calvo, M. Harjacek, Nico Wulffraat, Nicolino Ruperto

ANNALS OF THE RHEUMATIC DISEASES (2019)

Meeting Abstract Rheumatology

SYNOVIAL DERIVED TH17-LYMPHOCYTES FROM PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS INDUCE CARTILAGE DEGRADATION BY SYNOVIAL FIBROBLASTS MEDIATED BY MMP9 IN AN EXPERIMENTAL ANIMAL MODEL

T. Giani, F. Margheri, M. Del Rosso, L. Maggi, F. Annunziato, R. Cimaz

ANNALS OF THE RHEUMATIC DISEASES (2019)

Article Medicine, General & Internal

Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings

M. C. Maggio, R. Cimaz, A. Alaimo, C. Comparato, D. Di Lisi, G. Corsello

JOURNAL OF MEDICAL CASE REPORTS (2019)

Article Immunology

Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease

Sietse Q. Nagelkerke, Carline E. Tacke, Willemijn B. Breunis, Michael W. T. Tanck, Judy Geissler, Eileen Png, Long T. Hoang, Joris van der Heijden, Ahmad N. M. Naim, Rae S. M. Yeung, Michael L. Levin, Victoria J. Wright, David P. Burgner, Anne-Louise Ponsonby, Justine A. Ellis, Rolando Cimaz, Chisato Shimizu, Jane C. Burns, Karin Fijnyandraat, C. Ellen van der Schoot, Timo K. van den Berg, Martin de Boer, Sonia Davila, Martin L. Hibberd, Taco W. Kuijpers, Nagib Dahdah, Isabelle Kone-Paut

FRONTIERS IN IMMUNOLOGY (2019)

暂无数据